retatrutide plateau Retatrutide: What It Is & How This New Drug Works Retatrutide Side Effects Guide: 21

Some of the firstly described effects of GLP-1R agonists were those affecting the SNS [121,151]

Patnoe also emphasized focusing on health-promoting behaviors with patients rather than weight loss alone

Phase II studies revealed mean weight losses of 17.5% at 24 weeks and 24.4% at 48 weeks

In addition to acting on GLP-1 receptors, tirzepatide also targets GIP receptors located in the pancreas, adipose (fat) tissue, and brain regions involved in eating behavior and insulin regulation

These products are especially effective in helping users maintain adequate protein intake, which is critical for preserving muscle mass during weight loss